After Success Against COVID-19 Variants, Novavax Will File Vaccine First In UK
Efficacy Lower Against South Africa Strain
High efficacy in initial readout is good news for global vaccination, and UK will see first emergency use filing.
You may also be interested in...
Coronavirus Update: Pfizer Pledges To Double US Vaccine Output
A round-up of the latest developments, including Celltrion’s new antibody cocktail and SK Biosience and Novavax expanding their collaboration.
H1 Approvals Seen For Russian, Novavax COVID-19 Vaccines In India
Multiple COVID-19 vaccines, including from RDIF and Novavax, could get accelerated approvals in India in the first half of calendar 2021, expanding the range at the country’s disposal. J&J's vaccine is expected to follow although it still hasn’t begun local trials, while Pfizer has temporarily withdrawn an application.
Coronavirus Notebook: EU Publishes AstraZeneca Vaccine Contract, Implements Export Authorization Scheme
The AZ vaccine gets the regulatory go-ahead for use in the EU and the European Medicines Agency says an analysis of data on Pfizer/BioNTech’s Comirnaty has shown no new safety concerns.